Aceso Life Science Group Limited (HKG:0474)
Hong Kong · Delayed Price · Currency is HKD 0.1500
+0.0040 (2.74%)
Aug 21, 2026, 4:08 PM HKT
Aceso Life Science Group Revenue
In the fiscal year ending March 31, 2026, Aceso Life Science Group had annual revenue of -68.00M HKD. Aceso Life Science Group had revenue of -59.00M in the half year ending March 31, 2026.
Revenue
-68.00M
Revenue Growth
n/a
P/S Ratio
-19.54
Revenue / Employee
-2.43M
Employees
41
Market Cap
1.33B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | -68.00M | 3.00M | - |
| Mar 31, 2025 | -71.00M | -82.00M | - |
| Mar 31, 2024 | 11.00M | -196.00M | -94.69% |
| Mar 31, 2023 | 207.00M | 37.00M | 21.76% |
| Mar 31, 2022 | 170.00M | 299.00M | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Development Bank Financial Leasing | 18.49B |
| Horizon Construction Development | 10.43B |
| Chenqi Technology | 8.83B |
| CSSC (Hong Kong) Shipping Company | 3.15B |
| China Aircraft Leasing Group Holdings | 2.05B |
| Progressive Path Group Holdings | 841.32M |
| Dida Inc. | 559.12M |
| Kaisa Capital Investment Holdings | 237.51M |
Aceso Life Science Group News
- 8 days ago - Aceso Life Science Reports FY2026 Profit On Strategic Realignment - Nasdaq